Therapeutic targeting of STAT pathways in CNS autoimmune diseases

References

• Darnell JE Jr.. STATs and gene regulation. Science 1997; 277:1630 - 5; http://dx.doi.org/10.1126/science.277.5332.1630; PMID: 9287210
   PubMed Web of Science ®Google Scholar
• Levy DE, Darnell JE Jr.. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3:651 - 62; http://dx.doi.org/10.1038/nrm909; PMID: 12209125
   PubMed Web of Science ®Google Scholar
• Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2:410 - 6; PMID: 12093007
   PubMed Web of Science ®Google Scholar
• Wraith DC, Nicholson LB. The adaptive immune system in diseases of the central nervous system. J Clin Invest 2012; 122:1172 - 9; http://dx.doi.org/10.1172/JCI58648; PMID: 22466659
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3:879 - 89; http://dx.doi.org/10.1038/nri1224; PMID: 14668804
   PubMed Web of Science ®Google Scholar
• Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009; 9:440 - 7; http://dx.doi.org/10.1038/nri2548; PMID: 19444308
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990; 14:303 - 8; http://dx.doi.org/10.1007/BF00163549; PMID: 2249907
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997; 159:3109 - 12; PMID: 9317106
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Kozhich AT, Lobanoff M, Wolitzky BA, Chan CC. Blocking both E-selectin and P-selectin inhibits endotoxin-induced leukocyte infiltration into the eye. Clin Immunol Immunopathol 1997; 83:45 - 52; http://dx.doi.org/10.1006/clin.1996.4324; PMID: 9073535
   PubMedGoogle Scholar
• Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 2011; 1812:252 - 64; http://dx.doi.org/10.1016/j.bbadis.2010.06.017; PMID: 20619340
   PubMed Web of Science ®Google Scholar
• Liu X, Lee YS, Yu CR, Egwuagu CE. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J Immunol 2008; 180:6070 - 6; PMID: 18424728
   PubMed Web of Science ®Google Scholar
• Oh HM, Yu CR, Lee Y, Chan CC, Maminishkis A, Egwuagu CE. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 2011; 187:3338 - 46; http://dx.doi.org/10.4049/jimmunol.1004019; PMID: 21832158
   PubMed Web of Science ®Google Scholar
• Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007; 13:711 - 8; http://dx.doi.org/10.1038/nm1585; PMID: 17496900
   PubMed Web of Science ®Google Scholar
• Laurence A, O’Shea JJT. T(H)-17 differentiation: of mice and men. Nat Immunol 2007; 8:903 - 5; http://dx.doi.org/10.1038/ni0907-903; PMID: 17712339
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010; 28:445 - 89; http://dx.doi.org/10.1146/annurev-immunol-030409-101212; PMID: 20192806
   PubMed Web of Science ®Google Scholar
• Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, et al. Signaling and transcription in T helper development. Annu Rev Immunol 2000; 18:451 - 94; http://dx.doi.org/10.1146/annurev.immunol.18.1.451; PMID: 10837066
   PubMed Web of Science ®Google Scholar
• Nicoletti F, Patti F, Cocuzza C, Zaccone P, Nicoletti A, Di Marco R, et al. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 1996; 70:87 - 90; http://dx.doi.org/10.1016/S0165-5728(96)00101-4; PMID: 8862139
   PubMed Web of Science ®Google Scholar
• Meleth AD, Agrón E, Chan CC, Reed GF, Arora K, Byrnes G, et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46:4295 - 301; http://dx.doi.org/10.1167/iovs.04-1057; PMID: 16249511
   PubMed Web of Science ®Google Scholar
• Pierson E, Simmons SB, Castelli L, Goverman JM. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev 2012; 248:205 - 15; http://dx.doi.org/10.1111/j.1600-065X.2012.01126.x; PMID: 22725963
   PubMed Web of Science ®Google Scholar
• Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol Res 2003; 28:223 - 39; http://dx.doi.org/10.1385/IR:28:3:223; PMID: 14713716
   PubMed Web of Science ®Google Scholar
• Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher LH, Kuchroo VK. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004; 200:79 - 87; http://dx.doi.org/10.1084/jem.20031819; PMID: 15238607
   PubMed Web of Science ®Google Scholar
• Nishibori T, Tanabe Y, Su L, David M. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J Exp Med 2004; 199:25 - 34; http://dx.doi.org/10.1084/jem.20020509; PMID: 14699080
   PubMed Web of Science ®Google Scholar
• Lee YS, Amadi-Obi A, Yu CR, Egwuagu CE. Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Immunology 2011; 132:492 - 502; http://dx.doi.org/10.1111/j.1365-2567.2010.03379.x; PMID: 21294722
   PubMed Web of Science ®Google Scholar
• Egwuagu CE. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 2009; 47:149 - 56; http://dx.doi.org/10.1016/j.cyto.2009.07.003; PMID: 19648026
   PubMed Web of Science ®Google Scholar
• Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007; 19:409 - 17; http://dx.doi.org/10.1016/j.smim.2007.10.011; PMID: 18053739
   PubMed Web of Science ®Google Scholar
• Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999; 5:101 - 4; PMID: 10335518
   PubMed Web of Science ®Google Scholar
• Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 2007; 130:490 - 501; http://dx.doi.org/10.1093/brain/awl273; PMID: 17003070
   PubMed Web of Science ®Google Scholar
• Javed A, Reder AT. Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther 2006; 110:35 - 56; http://dx.doi.org/10.1016/j.pharmthera.2005.08.011; PMID: 16229894
   PubMed Web of Science ®Google Scholar
• Codarri L, Fontana A, Becher B. Cytokine networks in multiple sclerosis: lost in translation. Curr Opin Neurol 2010; 23:205 - 11; http://dx.doi.org/10.1097/WCO.0b013e3283391feb; PMID: 20442570
   PubMed Web of Science ®Google Scholar
• Aharoni R. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond. Autoimmun Rev 2012; In press PMID: 23051633
   PubMed Web of Science ®Google Scholar
• Liblau R, Steinman L, Brocke S. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int Immunol 1997; 9:799 - 803; http://dx.doi.org/10.1093/intimm/9.5.799; PMID: 9184926
   PubMed Web of Science ®Google Scholar
• Rizzo LV, Morawetz RA, Miller-Rivero NE, Choi R, Wiggert B, Chan CC, et al. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 1999; 162:2613 - 22; PMID: 10072503
   PubMed Web of Science ®Google Scholar
• Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 2002; 168:6506 - 13; PMID: 12055272
   PubMed Web of Science ®Google Scholar
• Muthian G, Raikwar HP, Johnson C, Rajasingh J, Kalgutkar A, Marnett LJ, et al. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. J Clin Immunol 2006; 26:73 - 85; http://dx.doi.org/10.1007/s10875-006-8787-y; PMID: 16418805
   PubMed Web of Science ®Google Scholar
• Xie L, Li XK, Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol 2011; 11:323 - 30; http://dx.doi.org/10.1016/j.intimp.2010.08.013; PMID: 20828641
   PubMed Web of Science ®Google Scholar
• Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009; 206:535 - 48; http://dx.doi.org/10.1084/jem.20082293; PMID: 19273625
   PubMed Web of Science ®Google Scholar
• Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 1999; 189:219 - 30; http://dx.doi.org/10.1084/jem.189.2.219; PMID: 9892605
   PubMed Web of Science ®Google Scholar
• Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007; 8:1372 - 9; http://dx.doi.org/10.1038/ni1540; PMID: 17994023
   PubMed Web of Science ®Google Scholar
• Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86:285 - 91; http://dx.doi.org/10.1016/j.ajhg.2010.01.017; PMID: 20159113
   PubMed Web of Science ®Google Scholar
• Yu CR, Lee YS, Mahdi RM, Surendran N, Egwuagu CE. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. PLoS One 2012; 7:e29742; http://dx.doi.org/10.1371/journal.pone.0029742; PMID: 22238646
   PubMed Web of Science ®Google Scholar
• Jager LD, Dabelic R, Waiboci LW, Lau K, Haider MS, Ahmed CM, et al. The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis. J Neuroimmunol 2011; 232:108 - 18; http://dx.doi.org/10.1016/j.jneuroim.2010.10.018; PMID: 21131060
   PubMed Web of Science ®Google Scholar
• Ahmed CM, Dabelic R, Martin JP, Jager LD, Haider SM, Johnson HM. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling. J Immunol 2010; 185:1103 - 13; http://dx.doi.org/10.4049/jimmunol.0902895; PMID: 20543109
   PubMed Web of Science ®Google Scholar
• Flowers LO, Johnson HM, Mujtaba MG, Ellis MR, Haider SM, Subramaniam PS. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J Immunol 2004; 172:7510 - 8; PMID: 15187130
   PubMed Web of Science ®Google Scholar
• Waiboci LW, Ahmed CM, Mujtaba MG, Flowers LO, Martin JP, Haider MI, et al. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J Immunol 2007; 178:5058 - 68; PMID: 17404288
   PubMed Web of Science ®Google Scholar
• Jetten AM. Immunology: A helping hand against autoimmunity. Nature 2011; 472:421 - 2; http://dx.doi.org/10.1038/472421a; PMID: 21525918
   PubMed Web of Science ®Google Scholar